Health X Platform AGM seeks approval for ₹500 crore borrowing limit
- AGM scheduled for September 28, 2026, via video conferencing
- Shareholders to approve ₹500 crore overall borrowing limit
- Reappointment of Mrs. Anjana Dikshit as Independent Director proposed
- Revised CA certificate confirms >50% revenue from healthcare activities

*this image is generated using AI for illustrative purposes only.
Health X Platform will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The agenda includes seeking shareholder approval for an overall borrowing limit of ₹500 crore and authorizing loans and guarantees up to ₹600 crore under Section 186 of the Companies Act, 2013.
The company also proposes creating mortgages or charges on assets to secure borrowings within the approved limits. Additionally, shareholders will vote on advancing loans or providing security to subsidiaries and group entities up to ₹200 crore under Section 185.
Governance and Director Reappointments
Mrs. Abha Mittal retires by rotation and offers herself for reappointment as a director. The Board recommends the reappointment of Mrs. Anjana Dikshit as an Independent Director for a second term of five years, from November 10, 2026, to November 9, 2031. Mrs. Dikshit serves on the Audit Committee and Stakeholders Relationship Committee.
Regulatory Compliance Update
The notice includes a revised certificate from statutory auditors JKVS & Co., dated April 9, 2026. This addresses stock exchange queries regarding revenue bifurcation for the name change from Sastasundar Ventures Limited to Health X Platform Limited. The certificate confirms that more than 50% of consolidated revenue comes from healthcare activities.
What the Numbers Show
The CA certificate discloses consolidated revenue figures for the period from January 1, 2025, to December 31, 2025. Healthcare activity generated ₹1,20,971.84 lakh, while financial services contributed ₹2,160.79 lakh. This results in total revenue of ₹1,23,132.63 lakh, with healthcare accounting for approximately 98% of the total, validating the regulatory requirement for the name change.
Meeting Details
Remote e-voting opens on September 25, 2026, at 9:00 am and closes on September 27, 2026, at 5:00 pm. The record date for voting rights is September 21, 2026. Mr. Raj Kumar Banthia has been appointed as the scrutinizer for the voting process.
Historical Stock Returns for Health X Platform
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.72% | +2.20% | -4.76% | +7.32% | +8.85% | +2.62% |
How will the approved ₹500 crore borrowing limit and ₹600 crore loan authorization accelerate Health X Platform's expansion into new healthcare segments or geographic markets?
What specific strategic initiatives or capital expenditures are the proposed loans to subsidiaries under Section 185 intended to fund?
Given that healthcare now constitutes 98% of revenue, how might investors' valuation multiples for Health X Platform shift compared to its previous classification as a diversified conglomerate?


































